Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial.
- DOI
- 10.1001/jamaneurol.2026.0902
- Published
- 2026-06-01
- Container
- JAMA Neurol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamaneurol.2026.0902,
title = {Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial.},
author = {Saccà F and Gialdini G and Howard JF and Vu TH and Meisel A and Peric S and Lünemann JD and Sgarzi M and Shaibani A and Bril V and Yeh JH and Reyes-Garrido V and Liao S and Metais C and van der Valk RJP and ALXN2050-MG-201 Investigators.},
year = {2026},
journal = {JAMA Neurol},
doi = {10.1001/jamaneurol.2026.0902},
url = {https://doi.org/10.1001/jamaneurol.2026.0902}
}RIS
TY - JOUR TI - Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial. AU - Saccà F AU - Gialdini G AU - Howard JF AU - Vu TH AU - Meisel A AU - Peric S AU - Lünemann JD AU - Sgarzi M AU - Shaibani A AU - Bril V AU - Yeh JH AU - Reyes-Garrido V AU - Liao S AU - Metais C AU - van der Valk RJP AU - ALXN2050-MG-201 Investigators. PY - 2026 JO - JAMA Neurol DO - 10.1001/jamaneurol.2026.0902 UR - https://doi.org/10.1001/jamaneurol.2026.0902 ER -
APA
F, S., G, G., JF, H., TH, V., A, M., S, P., JD, L., M, S., A, S., V, B., JH, Y., V, R., S, L., C, M., RJP, V. D. V., & Investigators., A. (2026). Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis: A Randomized Clinical Trial.. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2026.0902
Source records
- europe-pmc · retrieved 2026-09-26T10:57:00.645Z